Podcast: Patient advocates join the blood cancer ASCT vs CAR-T debate - Pharmaceutical Technology

Patient advocates in remission from MCL and FL discuss their treatment experiences with ASCT and CAR-T, while sharing views on latter's place in the treatment paradigm. Patient advocates in remission from MCL and FL discuss their experiences with treatment, as well as their views on CAR-T therapy’s place in managing blood cancers. In this podcast, patient advocates Peter Kapitein and Jonathan Clark discuss their blood cancer treatment experiences. Credit: Accogliente Design / Shutterstock.com. In recent years, there has been strong discourse in the blood cancer space around the best way to treat patients as the industry’s focus sharpens on keeping…

Source: Pharmaceutical Technology